The Biden administration wants to crack down on private arrangements among some hospitals to reimburse themselves for taxes that help fund coverage for low-income people. It contends the practice violates federal law.
Roivant discontinues blood cancer program as it fails to revive old Eisai drug, to dissolve Hemavant
Roivant disclosed Tuesday morning that it has stopped work on a treatment for myelodysplastic syndromes, a precursor disease to acute myeloid leukemia, after an interim analysis of
February 14, 2024